Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check20 days agoChange DetectedA site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.6%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision v3.7.0 has been added to the record history, replacing the previous v3.6.6.SummaryDifference0.2%

- Check76 days agoChange DetectedA new revision entry v3.6.6 is added to the page's history, updating the version shown in the record. This reflects a small system update rather than changes to study information or page content.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.